Phase 3, open-label trial of lenalidomide and low-dose dexamethasone with or without pembrolizumab (MK-3475) in newly diagnosed, treatment-naïve multiple myeloma who are ineligible for autologous stem cell transplant

June 2, 2017

Type of Cancer

Multiple Myeloma

Site

East Brunswick, Freehold, Howell, Little Silver, Mount Holly, Sparta

Sponsor

Merck

Protocol Number

3475-185

To Learn More Call

(201)-510-0950